Global Cardiopulmonary Bypass Equipment Industry 2015-2030 and Impact of COVID-19 - ResearchAndMarkets.com August 14, 2020 07:02 AM Eastern Daylight Time. DUBLIN-- ...

MONMOUTH JUNCTION, N.J., April 20, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commerciali ...

About The Study: The use of a nonselective extracorporeal blood purification device connected to the cardiopulmonary bypass circuit in a nonemergent population of patients undergoing cardiac ...

ABSTRACT Aprotinin is a polypeptide with serine protease inhibitory activity of key enzymes associated with inflammatory, fibrinolytic, and hemostatic pathways. The drug binds directly to the ...

A nonselective extracorporeal blood purifier connected to the cardiopulmonary bypass circuit during nonemergent cardiac surgery may help reduce post-surgical AKI, data show.“There are multiple ...

“The History of Goal-Directed Therapy and Relevance to Cardiopulmonary Bypass.” The journal of extra-corporeal technology vol. 47,2 (2015): 90-4. About LivaNova.

During open-heart surgery, blood is routed away from the child's heart and lungs through the cardiopulmonary bypass circuit that includes the oxygenation system, creating a bloodless and ...

The Global Heart Lung Machine Market was valued at US$ 0.3 Bn in 2020 and is projected to expand at a CAGR of 6.9% from 2021 to 2031.

Extracellular adenine nucleotides contribute to ischemia–reperfusion injury following infant cardiopulmonary bypass (CPB), whereas conversion to adenosine may be protective. Alkaline phosphatase ...

@FierceMedDev: Veracyte goes public, raises $65M and gains on Day 1. Article | Follow @FierceMedDev @MarkHFierce: Carlos Slim backs more genomics and Dx work at the Broad Institute, and elsewhere, ...